应用日本东菱精纯克栓酶治疗急性脑梗塞20例,与“传统”或“常规”治疗30例进行对照性研究。结果显示,克栓酶治疗组在用药后第3、7、14及28天卒中患者神经功能缺损程度评分均明显低于对照组,经统计学处理具有显著性差异,表明克栓酶治疗见效快、疗效好。提出溶栓治疗后继续应用其他脑血管病药物的联合治疗方法,并就东菱精纯克栓酶的作用机制进行了探讨。 20 cases of Acute Cerebral Infarction were treated with Dangling Purification of Japan, and 30 cases were treated with “traditional” or “routine” treatment. The results showed that the score of neurological impairment in stroke group was obviously lower than that of control group on the 3rd, 7th, 14th and 28th day after treatment with Kexu enzyme, and the difference was statistically significant , Good effect. Proposed thrombolytic therapy continue to use other combination therapy of cerebrovascular disease drugs, and Dongling Jingke acterase mechanism of action were discussed.